Intramuscular allosteric agonism of purinergic P2X7 receptor as a pharmacological approach to enhance skeletal muscle regeneration in Amyotrophic Lateral Sclerosis (FightMND administered by IRFMN) (2022–2025)
- Grant type:
- IRCCS - Istituto di Ricerche Farmacologiche Mario Negri
- Researchers:
-
-
Principal Research Fellow
Australian Institute for Bioengineering and Nanotechnology -
Associate Professor
School of Biomedical SciencesFaculty of Medicine
-
- Funded by:
- IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (externally led for Cure for MND Foundation)
